Tower Research Capital (TRC)’s NewAmsterdam Pharma NAMS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.92K | Sell |
548
-164
| -23% | -$2.97K | ﹤0.01% | 3974 |
|
|
2025
Q1 | $14.6K | Sell |
712
-585
| -45% | -$12K | ﹤0.01% | 3282 |
|
|
2024
Q4 | $33.3K | Sell |
1,297
-6,485
| -83% | -$167K | ﹤0.01% | 2827 |
|
|
2024
Q3 | $129K | Buy |
+7,782
| New | +$129K | ﹤0.01% | 2026 |
|
|
2023
Q1 | – | Sell |
-88
| Closed | -$1K | – | 6119 |
|
|
2022
Q4 | $1K | Buy |
+88
| New | +$1K | ﹤0.01% | 5633 |
|